461 related articles for article (PubMed ID: 10356627)
1. Desmopressin augments pituitary-adrenal responsivity to corticotropin-releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers.
Scott LV; Medbak S; Dinan TG
Biol Psychiatry; 1999 Jun; 45(11):1447-54. PubMed ID: 10356627
[TBL] [Abstract][Full Text] [Related]
2. Lack of effect of desmopressin on ACTH and cortisol responses to ovine corticotropin-releasing hormone in anorexia nervosa.
Foppiani L; Sessarego P; Valenti S; Falivene MR; Cuttica CM; Giusti Disem M
Eur J Clin Invest; 1996 Oct; 26(10):879-83. PubMed ID: 8911861
[TBL] [Abstract][Full Text] [Related]
3. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
[TBL] [Abstract][Full Text] [Related]
4. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
[TBL] [Abstract][Full Text] [Related]
5. Desmopressin and low-dose ACTH test in rheumatoid arthritis.
Foppiani L; Cutolo M; Sessarego P; Sulli A; Prete C; Seriolo B; Giusti M
Eur J Endocrinol; 1998 Mar; 138(3):294-301. PubMed ID: 9539304
[TBL] [Abstract][Full Text] [Related]
6. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
[TBL] [Abstract][Full Text] [Related]
7. Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome.
Scott LV; Medbak S; Dinan TG
Acta Psychiatr Scand; 1998 Jun; 97(6):450-7. PubMed ID: 9669518
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
Inder WJ; Ellis MJ; Evans MJ; Donald RA
Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
[TBL] [Abstract][Full Text] [Related]
9. ACTH and cortisol release following intravenous desmopressin: a dose-response study.
Scott LV; Medbak S; Dinan TG
Clin Endocrinol (Oxf); 1999 Nov; 51(5):653-8. PubMed ID: 10594528
[TBL] [Abstract][Full Text] [Related]
10. The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome.
Terzolo M; Reimondo G; Alì A; Borretta G; Cesario F; Pia A; Paccotti P; Angeli A
Clin Endocrinol (Oxf); 2001 May; 54(5):609-16. PubMed ID: 11380491
[TBL] [Abstract][Full Text] [Related]
11. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
Inder WJ; Prickett TC; Mulder RT
Clin Endocrinol (Oxf); 2005 Mar; 62(3):343-8. PubMed ID: 15730417
[TBL] [Abstract][Full Text] [Related]
12. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
[TBL] [Abstract][Full Text] [Related]
13. [Disorder of adrenal gland function in chronic fatigue syndrome].
Zarković M; Pavlović M; Pokrajac-Simeunović A; Cirić J; Beleslin B; Penezić Z; Ognjanović S; Savić S; Poluga J; Trbojević B; Drezgić M
Srp Arh Celok Lek; 2003; 131(9-10):370-4. PubMed ID: 15058215
[TBL] [Abstract][Full Text] [Related]
14. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome.
Cleare AJ; O'Keane V; Miell JP
Psychoneuroendocrinology; 2004 Jul; 29(6):724-32. PubMed ID: 15110921
[TBL] [Abstract][Full Text] [Related]
15. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.
Colombo P; Passini E; Re T; Faglia G; Ambrosi B
Clin Endocrinol (Oxf); 1997 Jun; 46(6):661-8. PubMed ID: 9274696
[TBL] [Abstract][Full Text] [Related]
16. Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome.
Scott LV; Burnett F; Medbak S; Dinan TG
Psychol Med; 1998 Mar; 28(2):285-93. PubMed ID: 9572086
[TBL] [Abstract][Full Text] [Related]
17. Desmopressin normalizes the blunted adrenocorticotropin response to corticotropin-releasing hormone in melancholic depression: evidence of enhanced vasopressinergic responsivity.
Dinan TG; Lavelle E; Scott LV; Newell-Price J; Medbak S; Grossman AB
J Clin Endocrinol Metab; 1999 Jun; 84(6):2238-40. PubMed ID: 10372738
[TBL] [Abstract][Full Text] [Related]
18. A pharmacological tool to assess vasopressinergic co-activation of the hypothalamus-pituitary-adrenal axis more integrally in healthy volunteers.
Jacobs GE; van Gerven JM; de Kam Ml; Elassaiss-Schaap J; Ruigt G; van Pelt J; Peeters BW; Peeters PA; Hulskotte EG
J Psychopharmacol; 2011 Mar; 25(3):361-9. PubMed ID: 20147570
[TBL] [Abstract][Full Text] [Related]
19. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
Azziz R; Black V; Hines GA; Fox LM; Boots LR
J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
Trainer PJ; Faria M; Newell-Price J; Browne P; Kopelman P; Coy DH; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
